{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:50:08Z","timestamp":1790675408711,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["LIH383"],"award-info":[{"award-number":["LIH383"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["AFR-3004509"],"award-info":[{"award-number":["AFR-3004509"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["AFR-14616593"],"award-info":[{"award-number":["AFR-14616593"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["15\/10358798"],"award-info":[{"award-number":["15\/10358798"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860229"],"award-info":[{"award-number":["860229"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["MSCA-ITN-2020-ETN"],"award-info":[{"award-number":["MSCA-ITN-2020-ETN"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["290847012 \/ FOR2372"],"award-info":[{"award-number":["290847012 \/ FOR2372"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["14254520"],"award-info":[{"award-number":["14254520"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["7.4520.21"],"award-info":[{"award-number":["7.4520.21"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["7.4529.19"],"award-info":[{"award-number":["7.4529.19"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["20\/15084569"],"award-info":[{"award-number":["20\/15084569"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["7.4593.19"],"award-info":[{"award-number":["7.4593.19"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["11012546"],"award-info":[{"award-number":["11012546"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["19\/14209621"],"award-info":[{"award-number":["19\/14209621"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["7.8504.20"],"award-info":[{"award-number":["7.8504.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.pharmthera.2021.108014","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T04:03:01Z","timestamp":1633492981000},"page":"108014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Atypical opioid receptors: unconventional biology and therapeutic opportunities"],"prefix":"10.1016","volume":"233","author":[{"given":"Christie B.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Meyrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Kostenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Chevign\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Szpakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0005","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/mol.119.117663","article-title":"Modulators of CXCR4 and CXCR7\/ACKR3 function","volume":"96","author":"Adlere","year":"2019","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0269881116689257","article-title":"Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents","volume":"31","author":"Altarifi","year":"2017","journal-title":"Journal of Psychopharmacology"},{"issue":"53","key":"10.1016\/j.pharmthera.2021.108014_bb0020","doi-asserted-by":"crossref","first-page":"27147","DOI":"10.1074\/jbc.M116.754887","article-title":"Targeted elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G protein-coupled receptor signaling","volume":"291","author":"Alvarez-Curto","year":"2016","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0030","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62552","article-title":"Beta-arrestin 2 germline knockout does not attenuate opioid respiratory depression","volume":"10","author":"Bachmutsky","year":"2021","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0035","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/pr.113.008136","article-title":"MAS and its related G protein-coupled receptors, Mrgprs","volume":"66","author":"Bader","year":"2014","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","article-title":"Opioids: Cellular mechanisms of tolerance and physical dependence","volume":"5","author":"Bailey","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"issue":"42","key":"10.1016\/j.pharmthera.2021.108014_bb0045","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuropharm.2014.06.005","article-title":"Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord","volume":"85","author":"Bannister","year":"2014","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108014_bb0055","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.bmcl.2011.01.138","article-title":"Development of 2,4-diaminopyrimidine derivatives as novel SNSR4 antagonists","volume":"21","author":"Bayrakdarian","year":"2011","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0060","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1038\/s41467-019-11875-6","article-title":"Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response","volume":"10","author":"Benredjem","year":"2019","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0065","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1189\/jlb.0106055","article-title":"Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration","volume":"81","author":"Bertram","year":"2007","journal-title":"Journal of Leukocyte Biology"},{"issue":"5449","key":"10.1016\/j.pharmthera.2021.108014_bb0070","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108014_bb0075","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.celrep.2015.02.045","article-title":"Cell-autonomous regulation of Mu-opioid receptor recycling by substance P","volume":"10","author":"Bowman","year":"2015","journal-title":"Cell Reports"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108014_bb0080","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1517\/13543776.2012.730521","article-title":"Bradykinin B1 receptor antagonists: a patent update 2009\u20132012","volume":"22","author":"Bozo","year":"2012","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0085","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/mol.106.022897","article-title":"Simultaneous activation of the delta opioid receptor (deltaOR)\/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling","volume":"70","author":"Breit","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"43","key":"10.1016\/j.pharmthera.2021.108014_bb0090","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1523\/JNEUROSCI.3769-07.2007","article-title":"Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria","volume":"27","author":"Bruchas","year":"2007","journal-title":"The Journal of Neuroscience"},{"issue":"26","key":"10.1016\/j.pharmthera.2021.108014_bb0095","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1074\/jbc.M513640200","article-title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes","volume":"281","author":"Bruchas","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0100","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1213\/01.ANE.0000152191.29311.9B","article-title":"Age-dependent opioid escalation in chronic pain patients","volume":"100","author":"Buntin-Mushock","year":"2005","journal-title":"Anesthesia and Analgesia"},{"issue":"26","key":"10.1016\/j.pharmthera.2021.108014_bb0105","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1073\/pnas.1300393110","article-title":"Discovery of positive allosteric modulators and silent allosteric modulators of the mu-opioid receptor","volume":"110","author":"Burford","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bph.12599","article-title":"Positive allosteric modulators of the mu-opioid receptor: A novel approach for future pain medications","volume":"172","author":"Burford","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108014_bb0115","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1523\/JNEUROSCI.09-09-03314.1989","article-title":"Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture","volume":"9","author":"Burgess","year":"1989","journal-title":"The Journal of Neuroscience"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108014_bb0120","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","article-title":"A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development","volume":"203","author":"Burns","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.bjp.0706448","article-title":"Characterization of the Mas-related gene family: Structural and functional conservation of human and rhesus MrgX receptors","volume":"147","author":"Burstein","year":"2006","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0143-4179(98)90022-1","article-title":"Ifenprodil blocks the excitatory effects of the opioid peptide dynorphin 1-17 on NMDA receptor-mediated currents in the CA3 region of the guinea pig hippocampus","volume":"32","author":"Caudle","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0135","author":"CDC"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-3-642-41199-1_14","article-title":"Arrestin-mediated activation of p38 MAPK: Molecular mechanisms and behavioral consequences","volume":"219","author":"Chavkin","year":"2014","journal-title":"Handbook of Experimental Pharmacology"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2021.108014_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1113\/jphysiol.1995.sp020541","article-title":"The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat","volume":"482","author":"Chen","year":"1995","journal-title":"The Journal of Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0150","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0022-3565(24)37335-5","article-title":"Dynorphin block of N-methyl-d-aspartate channels increases with the peptide length","volume":"284","author":"Chen","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0026-895X(25)13175-1","article-title":"Molecular cloning and functional expression of a mu-opioid receptor from rat brain","volume":"44","author":"Chen","year":"1993","journal-title":"Molecular Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/(SICI)1096-9861(19990614)408:4<549::AID-CNE8>3.0.CO;2-3","article-title":"Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons","volume":"408","author":"Commons","year":"1999","journal-title":"Journal of Comparative Neurology"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108014_bb0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1440-1681.1999.03049.x","article-title":"Opioid receptor signalling mechanisms","volume":"26","author":"Connor","year":"1999","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2021.108014_bb0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2004.03.056","article-title":"No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse","volume":"492","author":"Contet","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bph.12612","article-title":"Challenges for opioid receptor nomenclature: IUPHAR Review 9","volume":"172","author":"Cox","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0180","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/pr.112.007179","article-title":"International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands","volume":"65","author":"Davenport","year":"2013","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the mu-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"18","key":"10.1016\/j.pharmthera.2021.108014_bb0190","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0195-668X(03)00441-X","article-title":"Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension","volume":"24","author":"Dhamrait","year":"2003","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0195","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1213\/ANE.0000000000003887","article-title":"Side effect rates of opioids in equianalgesic doses via intravenous patient-controlled analgesia: A systematic review and network meta-analysis","volume":"129","author":"Dinges","year":"2019","journal-title":"Anesthesia and Analgesia"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR - Recommendations and Reports"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0205","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1208\/s12248-008-9056-1","article-title":"Opioid tolerance development: a pharmacokinetic\/pharmacodynamic perspective","volume":"10","author":"Dumas","year":"2008","journal-title":"The AAPS Journal"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108014_bb0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0006-2952(98)00088-4","article-title":"Opioid analgesics as noncompetitive N-methyl-d-aspartate (NMDA) antagonists","volume":"56","author":"Ebert","year":"1998","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.1205744","article-title":"Activation of kinin B1 receptors induces chemotaxis of human neutrophils","volume":"80","author":"Ehrenfeld","year":"2006","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.isci.2019.03.011","article-title":"Biased signaling of the Mu opioid receptor revealed in native neurons","volume":"14","author":"Ehrlich","year":"2019","journal-title":"iScience"},{"issue":"5090","key":"10.1016\/j.pharmthera.2021.108014_bb0225","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12974-019-1480-x","article-title":"Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitization","volume":"16","author":"Feehan","year":"2019","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0235","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/pr.59.1.3","article-title":"The endomorphin system and its evolving neurophysiological role","volume":"59","author":"Fichna","year":"2007","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0240","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pharmthera.2017.11.006","article-title":"Orphan neuropeptides and receptors: Novel therapeutic targets","volume":"185","author":"Fricker","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0245","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/s41467-020-18634-y","article-title":"The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication","volume":"11","author":"Fumagalli","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.peptides.2015.12.001","article-title":"Role of the non-opioid dynorphin peptide des-Tyr-dynorphin (DYN-A(2-17)) in food intake and physical activity, and its interaction with orexin-A","volume":"76","author":"Gac","year":"2016","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0255","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)30572-0","article-title":"The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog","volume":"198","author":"Gilbert","year":"1976","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"625","key":"10.1016\/j.pharmthera.2021.108014_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Science Signaling"},{"issue":"21","key":"10.1016\/j.pharmthera.2021.108014_bb0265","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0270","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41467-017-02661-3","article-title":"Lack of beta-arrestin signaling in the absence of active G proteins","volume":"9","author":"Grundmann","year":"2018","journal-title":"Nature Communications"},{"issue":"14","key":"10.1016\/j.pharmthera.2021.108014_bb0275","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1111\/bph.13809","article-title":"Targeting multiple opioid receptors - Improved analgesics with reduced side effects?","volume":"175","author":"Gunther","year":"2018","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0280","doi-asserted-by":"crossref","first-page":"14135","DOI":"10.1038\/ncomms14135","article-title":"Structural basis of ligand interaction with atypical chemokine receptor 3","volume":"8","author":"Gustavsson","year":"2017","journal-title":"Nature Communications"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108014_bb0285","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0196-9781(97)00259-3","article-title":"Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex","volume":"18","author":"Hackler","year":"1997","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03020955","article-title":"In the arms of Morpheus the development of morphine for postoperative pain relief","volume":"47","author":"Hamilton","year":"2000","journal-title":"Canadian Journal of Anaesthesia"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0295","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1189\/jlb.0208088","article-title":"A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells","volume":"84","author":"Hartmann","year":"2008","journal-title":"Journal of Leukocyte Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0300","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157015905774322516","article-title":"The sigma receptor: Evolution of the concept in neuropsychopharmacology","volume":"3","author":"Hayashi","year":"2005","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-021-01054-x","article-title":"Pharmacological and genetic manipulations at the mu-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice","author":"He","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108014_bb0310","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cub.2005.04.052","article-title":"An opiate cocktail that reduces morphine tolerance and dependence","volume":"15","author":"He","year":"2005","journal-title":"Current Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0315","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.pain.2013.12.008","article-title":"MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic pain","volume":"155","author":"He","year":"2014","journal-title":"Pain"},{"issue":"535","key":"10.1016\/j.pharmthera.2021.108014_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aao3134","article-title":"Oligomerization of MrgC11 and mu-opioid receptors in sensory neurons enhances morphine analgesia","volume":"11","author":"He","year":"2018","journal-title":"Science Signaling"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108014_bb0325","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0165-6147(97)90645-3","article-title":"The orphan opioid receptor and its endogenous ligand\u2014nociceptin\/orphanin FQ","volume":"18","author":"Henderson","year":"1997","journal-title":"Trends in Pharmacological Sciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0330","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/mol.118.115477","article-title":"Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3","volume":"96","author":"Heuninck","year":"2019","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0335","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/bcp.13564","article-title":"Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe","volume":"84","author":"Hider-Mlynarz","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"13","key":"10.1016\/j.pharmthera.2021.108014_bb0340","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/bph.14224","article-title":"The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception","volume":"175","author":"Hill","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0345","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-8993(00)01994-6","article-title":"Des-tyrosine(1) dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice","volume":"859","author":"Hiramatsu","year":"2000","journal-title":"Brain Research"},{"issue":"5536","key":"10.1016\/j.pharmthera.2021.108014_bb0350","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/258577a0","article-title":"Identification of two related pentapeptides from the brain with potent opiate agonist activity","volume":"258","author":"Hughes","year":"1975","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0355","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/cpt.2154","article-title":"A multipurpose first-in-human study with the novel CXCR7 antagonist ACT-1004-1239 using CXCL12 plasma concentrations as target engagement biomarker","volume":"109","author":"Huynh","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0360","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cell.2013.10.052","article-title":"Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior","volume":"155","author":"Ikeda","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568026043451618","article-title":"Opioid receptors and their ligands","volume":"4","author":"Janecka","year":"2004","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellsig.2017.01.005","article-title":"Novel signaling of dynorphin at kappa-opioid receptor\/bradykinin B2 receptor heterodimers","volume":"31","author":"Ji","year":"2017","journal-title":"Cellular Signalling"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/ALN.0b013e3181c53849","article-title":"Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor","volume":"112","author":"Juni","year":"2010","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108014_bb0380","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.neuropharm.2008.04.004","article-title":"Sex differences in hyperalgesia during morphine infusion: Effect of gonadectomy and estrogen treatment","volume":"54","author":"Juni","year":"2008","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0385","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.03.088","article-title":"Identification of MrgX2 as a human G-protein-coupled receptor for proadrenomedullin N-terminal peptides","volume":"330","author":"Kamohara","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"16","key":"10.1016\/j.pharmthera.2021.108014_bb0390","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0395","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fncel.2015.00229","article-title":"Functional expression of bradykinin B1 and B2 receptors in neonatal rat trigeminal ganglion neurons","volume":"9","author":"Kawaguchi","year":"2015","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"13","key":"10.1016\/j.pharmthera.2021.108014_bb0400","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of beta-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0405","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0410","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/mol.118.115329","article-title":"Atypical chemokine receptor 3 (ACKR3): A comprehensive overview of its expression and potential roles in the immune system","volume":"96","author":"Koenen","year":"2019","journal-title":"Molecular Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108014_bb0415","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ejca.2008.02.021","article-title":"Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients","volume":"44","author":"Kollender","year":"2008","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0420","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2006.01.014","article-title":"Identification of small molecule antagonists of the human mas-related gene-X1 receptor","volume":"351","author":"Kunapuli","year":"2006","journal-title":"Analytical Biochemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108014_bb0425","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","article-title":"Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice","volume":"31","author":"Kuzmin","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108014_bb0430","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/nn1804","article-title":"Dynorphin A activates bradykinin receptors to maintain neuropathic pain","volume":"9","author":"Lai","year":"2006","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0435","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neulet.2008.03.088","article-title":"Pronociceptive actions of dynorphin via bradykinin receptors","volume":"437","author":"Lai","year":"2008","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108014_bb0440","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","article-title":"In silico design of novel probes for the atypical opioid receptor MRGPRX2","volume":"13","author":"Lansu","year":"2017","journal-title":"Nature Chemical Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0445","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-017-4758-7","article-title":"Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain\/itch-stimulated and pain\/itch-depressed behaviors in male rats","volume":"235","author":"Lazenka","year":"2018","journal-title":"Psychopharmacology"},{"issue":"18","key":"10.1016\/j.pharmthera.2021.108014_bb0450","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1021\/ja501677q","article-title":"Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord","volume":"136","author":"Lee","year":"2014","journal-title":"Journal of the American Chemical Society"},{"issue":"22","key":"10.1016\/j.pharmthera.2021.108014_bb0455","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.bmcl.2016.10.010","article-title":"Cyclic non-opioid dynorphin A analogues for the bradykinin receptors","volume":"26","author":"Lee","year":"2016","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/pr.57.1.2","article-title":"International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences","volume":"57","author":"Leeb-Lundberg","year":"2005","journal-title":"Pharmacological Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0465","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nn815","article-title":"Proenkephalin A gene products activate a new family of sensory neuron\u2014specific GPCRs","volume":"5","author":"Lembo","year":"2002","journal-title":"Nature Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108014_bb0470","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.pain.2014.05.008","article-title":"Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in mice","volume":"155","author":"Li","year":"2014","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108014_bb0475","first-page":"E1996","article-title":"Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent pain","volume":"114","author":"Li","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0480","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1006\/mcne.2002.1150","article-title":"The alpha9\/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear","volume":"20","author":"Lioudyno","year":"2002","journal-title":"Molecular and Cellular Neurosciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0485","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1602\/neurorx.1.1.101","article-title":"Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults","volume":"1","author":"Lipton","year":"2004","journal-title":"NeuroRx"},{"issue":"7","key":"10.1016\/j.pharmthera.2021.108014_bb0490","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","article-title":"Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus","volume":"139","author":"Liu","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ph13020033","article-title":"Advances in CXCR7 modulators","volume":"13","author":"Lounsbury","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.pharmthera.2021.108014_bb0500","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jpain.2008.06.005","article-title":"Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia","volume":"9","author":"Luo","year":"2008","journal-title":"The Journal of Pain"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: Distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends in Neurosciences"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0510","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/jnc.15127","article-title":"Endomorphin analog exhibited superiority in alleviating neuropathic hyperalgesia via weak activation of NMDA receptors","volume":"155","author":"Ma","year":"2020","journal-title":"Journal of Neurochemistry"},{"issue":"7619","key":"10.1016\/j.pharmthera.2021.108014_bb0515","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108014_bb0520","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned mu, delta and kappa receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Research"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2021.108014_bb0525","first-page":"273S","article-title":"History and development of mixed opioid agonists, partial agonists and antagonists","volume":"7","author":"Martin","year":"1979","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108014_bb0530","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(89)90149-0","article-title":"A direct non-opiate interaction of dynorphin-(1-13) with the N-methyl-d-aspartate (NMDA) receptor","volume":"170","author":"Massardier","year":"1989","journal-title":"European Journal of Pharmacology"},{"issue":"7542","key":"10.1016\/j.pharmthera.2021.108014_bb0535","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108014_bb0540","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.RES.0000128404.65887.08","article-title":"Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: A critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways","volume":"94","author":"Medeiros","year":"2004","journal-title":"Circulation Research"},{"issue":"21","key":"10.1016\/j.pharmthera.2021.108014_bb0545","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.1903316116","article-title":"MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus","volume":"116","author":"Meixiong","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/j.pharmthera.2021.108014_bb0550","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd3226","article-title":"Pain market","volume":"9","author":"Melnikova","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0555","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acsmedchemlett.0c00163","article-title":"Discovery of diphenylacetamides as CXCR7 inhibitors with novel beta-arrestin antagonist activity","volume":"11","author":"Menhaji-Klotz","year":"2020","journal-title":"ACS Medicinal Chemistry Letters"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0560","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1471-4159.2006.03732.x","article-title":"Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor","volume":"97","author":"Merg","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0565","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1021\/acsptsci.1c00006","article-title":"Proadrenomedullin N-terminal 20 peptides (PAMPs) are agonists of the chemokine scavenger receptor ACKR3\/CXCR7","volume":"4","author":"Meyrath","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0570","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1038\/s41467-020-16664-0","article-title":"The atypical chemokine receptor ACKR3\/CXCR7 is a broad-spectrum scavenger for opioid peptides","volume":"11","author":"Meyrath","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0575","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Letters"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0580","first-page":"259","article-title":"Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan","volume":"69","author":"Monje","year":"2019","journal-title":"Revista Brasileira de Anestesiologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0585","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","article-title":"Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human","volume":"164","author":"Morgan","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2021.108014_bb0590","first-page":"659","article-title":"FDA approves first GPCR biased agonist","volume":"19","author":"Mullard","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0595","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1254\/jjp.76.233","article-title":"Evidence for the existence of the beta-endorphin-sensitive \u201cepsilon-opioid receptor\u201d in the brain: The mechanisms of epsilon-mediated antinociception","volume":"76","author":"Narita","year":"1998","journal-title":"Japanese Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0600","doi-asserted-by":"crossref","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navines-Ferrer","year":"2018","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108014_bb0605","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nri3544","article-title":"Immune regulation by atypical chemokine receptors","volume":"13","author":"Nibbs","year":"2013","journal-title":"Nature Reviews. Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0610","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(92)90821-K","article-title":"Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB101, does not induce either antinociceptive tolerance or cross-tolerance with morphine","volume":"223","author":"Noble","year":"1992","journal-title":"European Journal of Pharmacology"},{"issue":"16","key":"10.1016\/j.pharmthera.2021.108014_bb0615","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1073\/pnas.93.16.8677","article-title":"Primary structure and tissue distribution of the orphanin FQ precursor","volume":"93","author":"Nothacker","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0620","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/glia.22271","article-title":"The presumed atypical chemokine receptor CXCR7 signals through G(i\/o) proteins in primary rodent astrocytes and human glioma cells","volume":"60","author":"Odemis","year":"2012","journal-title":"Glia"},{"issue":"484","key":"10.1016\/j.pharmthera.2021.108014_bb0625","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal3395","article-title":"Genetic evidence that beta-arrestins are dispensable for the initiation of beta2-adrenergic receptor signaling to ERK","volume":"10","author":"O\u2019Hayre","year":"2017","journal-title":"Science Signaling"},{"issue":"25\u201326","key":"10.1016\/j.pharmthera.2021.108014_bb0630","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.lfs.2012.04.041","article-title":"Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand","volume":"90","author":"Parenti","year":"2012","journal-title":"Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1124\/pr.59.1.5","article-title":"International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers","volume":"59","author":"Pin","year":"2007","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0640","doi-asserted-by":"crossref","first-page":"109906","DOI":"10.1016\/j.cellsig.2020.109906","article-title":"Signaling diversity of mu- and delta- opioid receptor ligands: Re-evaluating the benefits of beta-arrestin\/G protein signaling bias","volume":"80","author":"Pineyro","year":"2021","journal-title":"Cellular Signalling"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.108014_bb0645","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.90.11.5057","article-title":"Molecular cloning, functional expression, and pharmacological characterization of an N-methyl-d-aspartate receptor subunit from human brain","volume":"90","author":"Planells-Cases","year":"1993","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25\u201326","key":"10.1016\/j.pharmthera.2021.108014_bb0650","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.lfs.2013.09.016","article-title":"Novel fentanyl-based dual mu\/delta-opioid agonists for the treatment of acute and chronic pain","volume":"93","author":"Podolsky","year":"2013","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0655","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-pharmtox-010715-103042","article-title":"The emerging role of spinal dynorphin in chronic pain: A therapeutic perspective","volume":"56","author":"Podvin","year":"2016","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"49","key":"10.1016\/j.pharmthera.2021.108014_bb0660","doi-asserted-by":"crossref","first-page":"85068","DOI":"10.18632\/oncotarget.18844","article-title":"ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration","volume":"8","author":"Puddinu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0665","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cyto.2018.02.024","article-title":"Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology","volume":"109","author":"Quinn","year":"2018","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0670","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0675","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1073\/pnas.0912852107","article-title":"Beta-arrestin- but not G protein-mediated signaling by the \u201cdecoy\u201d receptor CXCR7","volume":"107","author":"Rajagopal","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"24","key":"10.1016\/j.pharmthera.2021.108014_bb0680","doi-asserted-by":"crossref","first-page":"15864","DOI":"10.1021\/acs.jmedchem.0c01588","article-title":"Discovery of the potent, selective, orally available CXCR7 antagonist ACT-1004-1239","volume":"63","author":"Richard-Bildstein","year":"2020","journal-title":"Journal of Medicinal Chemistry"},{"issue":"45","key":"10.1016\/j.pharmthera.2021.108014_bb0685","doi-asserted-by":"crossref","first-page":"44400","DOI":"10.1074\/jbc.M302456200","article-title":"MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion","volume":"278","author":"Robas","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0690","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/npp.2011.155","article-title":"The mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control","volume":"37","author":"Rodriguez-Munoz","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0695","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.celrep.2019.01.049","article-title":"ACKR3 regulation of neuronal migration requires ACKR3 phosphorylation, but not beta-arrestin","volume":"26","author":"Saaber","year":"2019","journal-title":"Cell Reports"},{"issue":"1 Suppl","key":"10.1016\/j.pharmthera.2021.108014_bb0700","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0885-3924(99)00125-6","article-title":"NMDA-receptor antagonists in neuropathic pain: Experimental methods to clinical trials","volume":"19","author":"Sang","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-0-387-73657-0_49","article-title":"Cyclic dimers of C-terminal gamma2-MSH analogs as selective antagonists of the human sensory nerve-specific receptor (SNSR-4)","volume":"611","author":"Schmidt","year":"2009","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0710","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0022-3565(25)32472-9","article-title":"Pharmacological characterization of the epsilon-opiate receptor","volume":"216","author":"Schulz","year":"1981","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"37","key":"10.1016\/j.pharmthera.2021.108014_bb0715","doi-asserted-by":"crossref","first-page":"14759","DOI":"10.1073\/pnas.0702229104","article-title":"Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12\/SDF-1 receptor, CXCR7","volume":"104","author":"Sierro","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0720","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/JPR.S137952","article-title":"A randomized, Phase IIb study investigating oliceridine (TRV130), a novel micro-receptor G-protein pathway selective (mu-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty","volume":"10","author":"Singla","year":"2017","journal-title":"Journal of Pain Research"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0725","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.acr.2019.12.001","article-title":"The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy","volume":"145","author":"Sjoberg","year":"2020","journal-title":"Advances in Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0730","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-pharmtox-010919-023340","article-title":"The CXCL12\/CXCR4\/ACKR3 axis in the tumor microenvironment: Signaling, crosstalk, and therapeutic targeting","volume":"61","author":"Smit","year":"2021","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0735","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: From simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0740","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.phrs.2009.04.002","article-title":"Cooperative N-methyl-d-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain","volume":"60","author":"Sotgiu","year":"2009","journal-title":"Pharmacological Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108014_bb0745","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1073\/pnas.85.9.3245","article-title":"Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions","volume":"85","author":"Steranka","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0750","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1189\/jlb.2MR0815-383R","article-title":"vCCL2\/vMIP-II, the viral master KEYmokine","volume":"99","author":"Szpakowska","year":"2016","journal-title":"Journal of Leukocyte Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0755","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-021-00548-w","article-title":"The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3\/CXCR7","volume":"6","author":"Szpakowska","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0760","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bcp.2016.05.012","article-title":"Human herpesvirus 8-encoded chemokine vCCL2\/vMIP-II is an agonist of the atypical chemokine receptor ACKR3\/CXCR7","volume":"114","author":"Szpakowska","year":"2016","journal-title":"Biochemical Pharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.108014_bb0765","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/bph.14132","article-title":"Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3\/CXCR7 compared with CXCR4 and CXCR3","volume":"175","author":"Szpakowska","year":"2018","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2021.108014_bb0770","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13526","article-title":"Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders","volume":"31","author":"Szymaszkiewicz","year":"2019","journal-title":"Neurogastroenterology and Motility"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0775","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.lfs.2019.03.069","article-title":"Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts","volume":"224","author":"Tanaka","year":"2019","journal-title":"Life Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0780","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0022-3565(24)35164-X","article-title":"High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors","volume":"291","author":"Tang","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0785","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-8993(02)03180-3","article-title":"Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-d-aspartate receptor mechanism","volume":"952","author":"Tan-No","year":"2002","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0790","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pain.2004.11.004","article-title":"Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation","volume":"113","author":"Tan-No","year":"2005","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0795","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nchem.1050","article-title":"Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain","volume":"3","author":"Tarselli","year":"2011","journal-title":"Nature Chemistry"},{"issue":"23\u201324","key":"10.1016\/j.pharmthera.2021.108014_bb0800","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.lfs.2007.09.025","article-title":"Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins","volume":"81","author":"Terskiy","year":"2007","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0805","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.109.157446","article-title":"Comparison of the antinociceptive and antirewarding profiles of novel bifunctional nociceptin receptor\/mu-opioid receptor ligands: Implications for therapeutic applications","volume":"331","author":"Toll","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2021.108014_bb0810","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: Structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2021.108014_bb0815","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.0022-202X.2004.23518.x","article-title":"Kinin B2 receptor-coupled signal transduction in human cultured keratinocytes","volume":"124","author":"Vidal","year":"2005","journal-title":"The Journal of Investigative Dermatology"},{"issue":"4577","key":"10.1016\/j.pharmthera.2021.108014_bb0820","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1126\/science.6128791","article-title":"Nonopiate effects of dynorphin and des-Tyr-dynorphin","volume":"218","author":"Walker","year":"1982","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmthera.2021.108014_bb0825","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.physbeh.2010.08.018","article-title":"Progesterone rapidly recruits female-typical opioid-induced hyperalgesic mechanisms","volume":"101","author":"Waxman","year":"2010","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0830","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2012.02.041","article-title":"Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists","volume":"51","author":"Wijtmans","year":"2012","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"356","key":"10.1016\/j.pharmthera.2021.108014_bb0835","doi-asserted-by":"crossref","first-page":"pe41","DOI":"10.1126\/stke.3562006pe41","article-title":"D-serine regulation of NMDA receptor activity","volume":"2006","author":"Wolosker","year":"2006","journal-title":"Science's STKE"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2021.108014_bb0840","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(95)00728-8","article-title":"Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: Binding at mu-opioid receptors","volume":"297","author":"Wong","year":"1996","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.108014_bb0845","first-page":"534","article-title":"Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control","volume":"21","author":"Wong","year":"1996","journal-title":"Regional Anesthesia"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0850","first-page":"171","article-title":"Multiple opioid receptor systems in brain and spinal cord: Part I","volume":"1","author":"Yaksh","year":"1984","journal-title":"European Journal of Anaesthesiology"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0855","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48431","article-title":"MRGPRX4 is a bile acid receptor for human cholestatic itch","volume":"8","author":"Yu","year":"2019","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.108014_bb0860","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0006-8993(89)91192-X","article-title":"Characterization of zeta (zeta): A new opioid receptor involved in growth","volume":"482","author":"Zagon","year":"1989","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2021.108014_bb0865","doi-asserted-by":"crossref","unstructured":"Zhu, J., Chen, C., Xue, J. C., Kunapuli, S., DeRiel, J. K., & Liu-Chen, L. Y. (1995). Cloning of a human kappa opioid receptor from the brain. Life Sciences, 56 (9), PL201-207.","DOI":"10.1016\/0024-3205(94)00507-O"},{"issue":"6685","key":"10.1016\/j.pharmthera.2021.108014_bb0870","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:01:47Z","timestamp":1778623307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":174,"alternative-id":["S0163725821002163"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108014","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical opioid receptors: unconventional biology and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108014"}}